Global Subcutaneous Immunoglobulins Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

Immunoglobulin therapy, also known as normal human immunoglobulin (NHIG), is the use of a mixture of antibodies (immunoglobulins) to treat a number of health conditions.The first description of a subcutaneous route of administration for immunoglobulin therapy dates back to 1980, but for many years subcutaneous administration was considered to be a secondary choice, only to be considered when peripheral venous access was no longer possible or tolerable.Although intravenous was the preferred route for immunoglobulin therapy for many years, in 2006 the FDA approved the first preparation of immunoglobulin that was designed exclusively for subcutaneous use. The Subcutaneous Immunoglobulins market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Subcutaneous Immunoglobulins market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Subcutaneous Immunoglobulins Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Subcutaneous Immunoglobulins market are: Bio Products Laboratory Ltd. Kedrion S.p.A Takeda Pharmaceutical Company Limited LFB S.A. Grifols S.A. CSL Limited Octapharma AG Biotest AG Most important types of Subcutaneous Immunoglobulins products covered in this report are: 10% Purity 20% Purity Most widely used downstream fields of Subcutaneous Immunoglobulins market covered in this report are: Primary Immunodeficiency Secondary Immunodeficiency Others Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.